TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/3/04 10:30 | 12/2/04 | ILXO | Ilex Oncology Inc | DE | Health | BioPrd | Biological Products, (No Diag | Watson Mark E Jr | TX | D | S | -25 | 25.00 | 0 | -1 | -4 | 23 | D | |||||||||||||||
11/23/04 10:28 | 11/22/04 | ILXO | Ilex Oncology Inc | DE | Health | BioPrd | Biological Products, (No Diag | Watson Mark E Jr | TX | D | S | -25 | 24.87 | 0 | -1 | -4 | 24 | D | |||||||||||||||
11/17/04 12:39 | 11/16/04 | ILXO | Ilex Oncology Inc | DE | Health | BioPrd | Biological Products, (No Diag | Watson Mark E Jr | TX | D | S | -50 | 25.15 | 0 | -2 | -7 | 25 | D | |||||||||||||||
11/8/04 11:30 | 11/5/04 | ILXO | Ilex Oncology Inc | DE | Health | BioPrd | Biological Products, (No Diag | Watson Mark E Jr | TX | D | S | -51 | 25.54 | 0 | -2 | -7 | 27 | D | |||||||||||||||
10/4/04 13:00 | 10/1/04 | ILXO | Ilex Oncology Inc | DE | Health | BioPrd | Biological Products, (No Diag | Watson Mark E Jr | TX | D | S | -254 | 25.37 | 0 | -10 | -26 | 29 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |